FCBIOTECH SPÓŁKA AKCYJNA
UL. BOHDANA DOBRZAŃSKIEGO 3, 20-262 LUBLIN
TAX ID5213679395
Rate company:
FCBIOTECH SPÓŁKA AKCYJNA
TAX ID5213679395
KRS0000524561
Share capital100,000.00 zł
address
UL. BOHDANA DOBRZAŃSKIEGO 3, 20-262 LUBLIN
Website
www.fcbiotech.plCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5213679395 
REGON
147434747
KRS
0000524561
Legal form
joint stock company
Register Address
UL. BOHDANA DOBRZAŃSKIEGO 3, 20-262 LUBLIN
Date of registration in KRS
2014-09-24
Date of commencement of economic activity
2014-09-24
Act signature
LU.VI NS-REJ.KRS/29147/24/859
Website
WWW.FCBIOTECH.PL
Pkd codes
72.11.Z - Research and experimental development on biotechnology
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
70.22.Z - Business and other management consultancy activities
71.20.A - Food quality testing and analysis
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
74.10.Z - Specialised design activities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL51 1050 1012 1000 0090 3040 0247 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale  | -11,4 | -67,8 | 1,1 | 101,6 |
Gross profit (loss) | -12 | -89,5 | -0,8 | 99,1 |
EBITDA | -9,4 | -88,1 | 1,1 | 101,3 |
Short time liabilities | 253,6 | 346,5 | 301,9 | -12,9 |
Other operating costs | 0,6 | 20,3 | 0 | -100 |
Equity capital | 40,6 | -48,9 | -49,7 | -1,7 |
Operating profit (EBIT) | -12 | -88,1 | 1,1 | 101,3 |
Assets | 329,2 | 303,6 | 258,2 | -15 |
Net profit (loss) | -12 | -89,5 | -0,8 | 99,1 |
Cash | 68 | 1,3 | 7,4 | 481,9 |
Liabilities and provisions for liabilities | 6 | 352,5 | 307,9 | -12,7 |
Net income from sale | 527,3 | 510,7 | 623 | 22 |
Working assets | 317,3 | 302,5 | 252,8 | -16,4 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 2,6 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -29,5 | 183,1 | 1,7 | -181,4 |
Equity capital to total assets | 12,3 | -16,1 | -19,3 | -3,2 |
Gross profit margin | -2,3 | -17,5 | -0,1 | 17,4 |
EBITDA Margin | -1,8 | -17,3 | 0,2 | 17,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 176 | 248 | 177 | -71 |
Current financial liquidity indicator | 1.2512058019638062 | 0.8729439973831177 | 0.8371465802192688 | -0,1 |
Financial statements
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
INVIGEN SPÓŁKA AKCYJNA
WARSZAWA
India Gold sp. z o.o.
Warszawa
KATARZYNA KRZYSTANEK
Częstochowa
LIFESPAN MOLECULES SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
BIELANY WROCŁAWSKIE